Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Activists from Doctors Without Borders protest vaccine pricing policies in front of the Pfizer World Headquarters in New York NY, Thursday, April 22, 2015. Pfizer refuses to publish the price of the pnuemococcal vaccine, preventing developing countries from negotiating a fair price for the drug. Photograph by Victor J. Blue
Press release
Press release |
12 November 2015
Vaccines

MSF launches global action against Pfizer and GlaxoSmithKline to cut the price of the pneumonia vaccine

Metro advertisements for Doctors Without Borders, 2015. Photograph by Drew Angerer
Press release
Press release |
05 November 2015
Intellectual property and trade

Statement by MSF on the official release of the full text of the Trans-Pacific Partnership trade agreement

3 min
MSF collaborates with national authorities and NGOs (FORSANI, Befem/Alima) to reduce under-five mortality in several regions of Niger, with a particular focus on the management of children with severe malnutrition and malaria. Photograph by Krishan Cheyenne
Press release
Press release |
03 November 2015
Intellectual property and trade

MSF responds to least-developed country IP exemption deal

2 min
Weekly meeting of the local medical staff with the supervising and counselling staff of MSF. Photograph by Helmut Wachter
Press release
Press release |
28 October 2015
Tuberculosis

Global TB report reveals rate of diagnosis for multi-drug resistant TB cases is heading in the wrong direction

A woman holds a sign at the Stop Stock Outs (SSP) activist meeting in Soshanguve, a township outside of Pretoria on April 16, 2015. Photograph by Stefan Heunis
Press release
Press release |
27 October 2015
HIV/AIDS Intellectual property and trade
South Africa

South Africa Should Override Patent on Key HIV Medicine After Widespread Stock Out Problem

5 min
After a year of "remote control" support, MSF is again present in the health zone of Birambizo, in the province of North Kivu, Democratic Republic of Congo. Photograph by Emily Lynch
Press release
Press release |
26 October 2015
Intellectual property and trade
KenyaIndia

At African Union–India meeting in Delhi, African leaders and India should work together to protect access to affordable medicines

3 min
A malaria flare killed dozens in the beginning of 2015 in Ziralo, eastern DRC. Number of cases has not decreased but MSF intervention managed to help decreasing the mortality. Photograph by Anna Surinyach
Press release
Press release |
23 October 2015
Malaria Research and development

MSF response on WHO guidance on malaria vaccine RTS,S

A patient with TB shows the pills for his treatment in a prison in Donetsk, Ukraine, where MSF is helping to treat patients infected with TB. MSF has been running a TB treatment program within the penitentiary system in Donetsk since 2011. Photograph by Manu Brabo
Press release
Press release |
14 October 2015
Intellectual property and trade
European Union

HAI and MSF Report Shows European Commission’s Access to Medicines Commitments are ‘Empty Gestures’

3 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury